Literature DB >> 6427608

Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.

S W Brusilow, M Danney, L J Waber, M Batshaw, B Burton, L Levitsky, K Roth, C McKeethren, J Ward.   

Abstract

Although normal plasma ammonium levels can be maintained in children with inborn errors of ureagenesis, these children are vulnerable to episodic hyperammonemia often resulting in coma and death. To treat such episodes, we designed a therapeutic protocol that included prompt recognition of hyperammonemia, therapy with intravenous sodium benzoate, sodium phenylacetate, and arginine, and nitrogen-free intravenous alimentation. Dialysis was performed if the hyperammonemia was unresponsive to drug therapy. Twelve episodes of hyperammonemia in seven children deficient in carbamyl phosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase were treated; one patient died and the others recovered. In two patients measurement of the distribution of urinary nitrogen revealed that hippurate nitrogen and phenylacetylglutamine nitrogen together accounted for 60 per cent of "effective" urinary waste nitrogen. Successful therapy of episodic hyperammonemia plays an important part in the long-term management of disorders of the urea cycle.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427608     DOI: 10.1056/NEJM198406213102503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

1.  Life extension in Drosophila by feeding a drug.

Authors:  Hyung-Lyun Kang; Seymour Benzer; Kyung-Tai Min
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

2.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.

Authors:  M Yudkoff; Y Daikhin; I Nissim; A Jawad; J Wilson; M Batshaw
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 4.  Advances in urea cycle neuroimaging: Proceedings from the 4th International Symposium on urea cycle disorders, Barcelona, Spain, September 2013.

Authors:  Ileana Pacheco-Colón; Stanley Fricke; John VanMeter; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2014-05-20       Impact factor: 4.797

5.  Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.

Authors:  V Praphanphoj; S A Boyadjiev; L J Waber; S W Brusilow; M T Geraghty
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

Review 6.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

Review 7.  Metabolic syndromes with dermatologic manifestations.

Authors:  M Irons; H L Levy
Journal:  Clin Rev Allergy       Date:  1986-02

8.  Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.

Authors:  D Samid; S Shack; C E Myers
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Orthotopic liver transplantation for urea cycle enzyme deficiency.

Authors:  S Todo; T E Starzl; A Tzakis; K J Benkov; F Kalousek; T Saheki; K Tanikawa; W A Fenton
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

10.  Peritoneal dialysis in neonates with inborn errors of metabolism: is it really out of date?

Authors:  Ivana Pela; Daniela Seracini; Maria Alice Donati; Giancarlo Lavoratti; Elisabetta Pasquini; Marco Materassi
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.